Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01379066 · ClinicalTrials.gov registry record
Tuberculosis Volatile Organic Compounds
A clinical trial, sponsored by Landon Pediatric Foundation.
- Completed
- Registry status
- 15
- Enrollment target
NCT01379066 is a clinical trial that has completed, run by Landon Pediatric Foundation. The registered enrollment target is 15 participants.
The verdict
NCT01379066 has completed, sponsored by Landon Pediatric Foundation.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The Pulmonary Colonization Test is a non-invasive breath test for markers of lower respiratory tract infection, which may predict the probability of mycobacterial organisms in the lower respiratory tract. It consists of: * A breath collection apparatus for collection of volatile organic compounds in breath onto a sorbent trap and Tedlar bag, as well as for the collection of a separate sample of room air. * Analysis of the volatile organic compounds in breath and room air by short acoustic wave/gas chromatography. * Interpretation of the volatile organic compounds with a proprietary algorithm in order to predict the probability of lower respiratory tract colonization and infection. * Analysis of the volatile organic compounds in sputum culture by short acoustic wave/gas chromatography. This study will test the hypothesis that the investigators can identify the presence of mycobacteria in an individual by sampling the breath of patients with active tuberculosis and by sampling "head space" above culture media of sputum provided. This study will test the hypotheses: * that the investigators can identify positive cultures for mycobacterium tuberculosis through sampling of the headspace above the cultures prior to standard laboratory culture identification * that the investigators can identify control of tuberculosis by sampling exhaled breath
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01379066
The ClinicalTrials.gov registry entry for NCT01379066 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Landon Pediatric Foundation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01379066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01379066 about?
NCT01379066 is a clinical study titled "Tuberculosis Volatile Organic Compounds". The Pulmonary Colonization Test is a non-invasive breath test for markers of lower respiratory tract infection, which may predict the probability of mycobacterial organisms in the lower respiratory tract. It consists of: * A breath collection apparatus for collection of volatile organic compounds i...
What is the current status of trial NCT01379066?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2009-08. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01379066?
This trial is sponsored by Landon Pediatric Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.